phosphorus has been researched along with 6-amino-1-hydroxyhexane-1,1-diphosphonate in 1 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (6-amino-1-hydroxyhexane-1,1-diphosphonate) | Trials (6-amino-1-hydroxyhexane-1,1-diphosphonate) | Recent Studies (post-2010) (6-amino-1-hydroxyhexane-1,1-diphosphonate) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 100 | 27 | 37 |
Protein | Taxonomy | phosphorus (IC50) | 6-amino-1-hydroxyhexane-1,1-diphosphonate (IC50) |
---|---|---|---|
Farnesyl pyrophosphate synthase | Homo sapiens (human) | 2.9965 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anastasi, G; Franchina, F; Frisina, N; Galì, A; Gaudio, A; Magno, C; Maisano, D; Melloni, D; Morabito, N | 1 |
1 trial(s) available for phosphorus and 6-amino-1-hydroxyhexane-1,1-diphosphonate
Article | Year |
---|---|
Preventing bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Amino Acids; Androgen Antagonists; Anilides; Biomarkers; Bone Density; Calcium; Chromatography, High Pressure Liquid; Diphosphonates; Drug Therapy, Combination; Estradiol; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Nitriles; Osteoporosis; Parathyroid Hormone; Phosphorus; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Treatment Outcome; Vitamin D | 2005 |